Kaiser Permanente Santa Clara Medical Center — Santa Clara, California

Kaiser Permanente Santa Clara Medical Center is a clinical research site located in Santa Clara, California, United States 95051.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Kaiser Permanente Santa Clara Medical Center has participated in 14 clinical trials with 7 currently active.

Therapeutic areas: Breast Cancer, Hemophilia A, RSV Immunization.

Sponsors: Alliance Foundation Trials, LLC., Spark Therapeutics, Inc., Sanofi Pasteur, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Santa Clara

Browse all research sites in California · View every site in Santa Clara

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kaiser Permanente Santa Clara Medical Center?

Kaiser Permanente Santa Clara Medical Center has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kaiser Permanente Santa Clara Medical Center conducted?

Kaiser Permanente Santa Clara Medical Center has 14 clinical trials on record, with 7 currently active. Their work covers Breast Cancer, Hemophilia A, RSV Immunization.

Is Kaiser Permanente Santa Clara Medical Center accredited by Crixeo Clinical Trials?

Kaiser Permanente Santa Clara Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kaiser Permanente Santa Clara Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.